ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years
Shuai Yuan
Matched on ORCID iD 0000-0001-5055-5627; OpenAlex author ID A5076350483. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2022: 1 paper · 2023: 1 paper · 2024: 1 paper
Papers 3
- Prognostic and diagnostic value of circulating IGFBP2 in pancreatic cancer. Co-author DOI 10.1515/med-2023-0893↗
- SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation. Co-author DOI 10.1136/gutjnl-2022-327492↗
- SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC. Co-author DOI 10.7150/ijbs.64752↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shengyu Yang · 2 shared papers, 2022–2023 · strength 0.28
- Song Gao · 2 shared papers, 2022–2023 · strength 0.28
- Jihui Hao · 2 shared papers, 2022–2023 · strength 0.28
- Jie Xu · 1 shared paper, 2024 · strength 0.28
- Song Gao · 1 shared paper, 2024 · strength 0.28
- Yizhang Zhou · 1 shared paper, 2022 · strength 0.15
- Mingxiao Lang · 1 shared paper, 2022 · strength 0.15
- Zhe Liu · 1 shared paper, 2022 · strength 0.15
- Danqi Fu · 1 shared paper, 2023 · strength 0.13
- Chongbiao Huang · 1 shared paper, 2023 · strength 0.13
- Wenna Jiang · 1 shared paper, 2023 · strength 0.13
- Yongjie Xie · 1 shared paper, 2023 · strength 0.13
- Tianxing Zhou · 1 shared paper, 2023 · strength 0.13
- Jing Liu · 1 shared paper, 2023 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.